News Headlines Article

FDA approves first drug for form of thyroid cancer
Los Angeles Times

Federal regulators Wednesday approved the first drug treatment for a rare form of late-stage thyroid cancer.

Patients with metastatic medullary thyroid cancer who received the drug, vandetanib, went an additional six months without progression of disease compared to patients who received a sugar pill, according to a statement by the Food and Drug Administration.

It is too soon to tell whether the additional time without progression of the disease will translate into longer survival, the FDA said.

Commands